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This study was designed to evaluate the in vivo effect of 
acetylcholine on endothelial-damaged canine epicardial 
coronary arteries and the potential contribution of platelets 
to those acetylcholine-induced responses. Changes in left 
anterior descending artery cross-sectional area were deter- 
mined by quantitative angiography in the closed chest 
anesthetized dog. Baseline cross-sectional area of the left 
anterior descending artery was not changed by removal of 
the endothelium by balloon-tipped catheter. 
Increased constrictor tone produced by prostaglandin 
F,, was comparable in endothelium-intact and endotheli- 
urn-removed vessels, supporting an endothelium-indepen- 
dent mechanism for prostaglandin F,, in vivo. Acetylcho- 
line produced anterior descending artery vasodilation with 
the endothelium intact; a comparable maximal dilator 
response was also obtained in the presence of increased 
constrictor tone (prostaglandin F&. In contrast, acetylcho- 
line produced vasoconstriction of the anterior descending 
artery when the endothelium was removed. To evaluate the 
mechanism of acetylcholine-induced vasoconstriction in en- 
The regulation of epicardial coronary arteries remains a 
significant issue with regard to abnormalities in vasomotion 
(1,2). Relative to this issue, the endothelium has been shown 
to be a significant modulator of vascular smooth muscle 
contraction (3-6) and, therefore, the loss of endothelium- 
dependent vasodilator mechanisms as a result of endothelial 
damage or disease may contribute to the production of 
From the Division of Cardiovascular Diseases and Internal Medicine and 
Department of Anatomy, Mayo Clinic and Mayo Foundation, Rochester, 
Minnesota. This study was supported by a grant from the Upjohn Company, 
Kalamazoo, Michigan and by funds from the Mayo Foundation, Rochester, 
Minnesota and the Pepsico Foundation, Purchase, New York. 
Manuscript received December 21, 1988; revised manuscript received 
April 19, 1989, accepted June 7, 1989. 
Add ess for remin&: Wayne L. Miller, MD, Division of Cardiovascular 
Disease: Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905. 
dothelium-removed vessels, the same protocol was com- 
pleted in the presence of the platelet inhibitor indometh- 
acin. Indomethacin did not alter baseline cross-sectional 
area or the dilator response to acetylcholine in endotheli- 
urn-intact vessels. In contrast, the constrictor response in 
endothelium-removed vessels was antagonized, and a dila- 
tor response comparable with that in endothelium-intact 
vessels was produced by acetylcholine. 
The results of this study provide an experimental basis 
for the observations in human studies in which apparently 
atherosclerotic vessels constrict in response to acetylcho- 
line. Removal of the endothelium in vivo abolishes the 
dilator response to acetylcholine and converts the acetyl- 
choline response to vasoconstriction or vasospasm. This 
vasoconstrictor response is reversed to a dilator response by 
indomethacin, suggesting that acetylcholine-induced vaso- 
constriction in endothelial-damaged arteries in vivo may, in 
part, be facilitated by platelet-released vasoconstricting 
substances. 
(J Am Co11 Cardiol1989;14:1794-802) 
pathologic vasoconstriction. Endothelium-dependent va- 
sorelaxation was first described for acetylcholine (6), but 
controversy exists with regard to species-specific responses 
to acetylcholine. Removal of the endothelium results in the 
loss of the vasodilator response to acetylcholine in isolated 
and in vivo canine coronary arteries (7,8). In contrast, 
acetylcholine-induced contraction of isolated human and 
porcine coronary arteries with intact endothelium has been 
reported (9). In addition, vasoconstrictor responses to ace- 
tylcholine in vessels with the endothelium removed have 
been reported for isolated rabbit coronary arteries (10) and 
canine femoral arteries in situ (II), but findings are not 
consistent (4,11,12). 
Angiographic studies (13) in humans with atherosclerosis 
demonstrated dose-dependent acetylcholine-induced con- 
striction of the left anterior descending coronary artery, 
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whereas angiographically normal coronary vessels showed 
vasodilation induced by acetylcholine. In addition, acetyl- 
choline has been reported (14-16) to induce coronary artery 
vasospasm in patients with variant angina. These findings 
suggest that endothelial removal or injury not only may 
abolish endothelium-dependent vasodilation, but also may 
contribute to deleterious coronary artery vasoconstriction or 
spasm. Endothelial dysfunction was, however, not docu- 
mented in these studies. No studies have been reported that 
evaluate endothelium-dependent response to acetylcholine 
in coronary arteries in vivo under conditions without prior 
surgical manipulation of the vascular bed where endothelial 
dysfunction was demonstrated under controlled conditions. 
In addition, the role of platelets in contributing to epicar- 
dial coronary vessel in vivo responses to acetylcholine has 
not been elucidated. Aggregating platelets demonstrate va- 
sorelaxing and vasoconstricting effects in vitro, depending 
on the presence or absence of endothelium (17) and platelets 
have been shown (18) to be deposited in significant numbers 
at the sites of endothelial damage in vivo. Acetylcholine has 
also been shown (19) in vitro to promote platelet aggregation 
and release of vasoactive substances. Therefore, the inter- 
action of platelets with acetylcholine in the presence of 
endothelial damage may provide a basis for the vasoconstric- 
tion to acetylcholine observed in human atherosclerotic 
coronary arteries (13,20,2 I). 
The objectives of this study, therefore, were 1) to estab- 
lish a closed chest canine model that would permit the 
testing of the responses of epicardial coronary arteries to 
Rcetylcholine under conditions in which the endothelium 
was intact and then removed; and 2) to test the hypothesis 
that indomethacin, an inhibitor of platelet aggregation and 
cyclooxygenase, would alter the response to acetylcholine of 
the endothelium-damaged epicardial coronary artery. 
Methods 
Experimental preparation. Ten male dogs weighing 20 to 
27 kg were studied. Animal studies herein described conform 
to the “Position of the American Heart Association on 
Research Animal Use” adopted November 11, 1984 by the 
American Heart Association. Each dog was anesthetized 
with fentanyl (2.0 mgikg body weight intravenously), nitrous 
oxide (70%) and oxygen (30%) provided by a Harvard 
respirator through a cuffed endotracheal tube. Fentanyl has 
previously been demonstrated (22) to have no significant 
effect on canine coronary artery function. After induction of 
anesthesia, a 6F coronary sinus catheter was placed under 
fluoroscopic guidance through the right jugular vein for 
blood sampling and cardiac pacing. A catheter was also 
placed in the left femoral artery and positioned for monitor- 
ing of thoracic aortic blood pressure and for sampling of 
arterial blood. In addition, a specially designed coronary 
artery catheter was advanced under fluoroscopic guidance 
from the left carotid artery to the left coronary ostium. The 
coronary catheter was a two catheter system consisting of a 
2.5 mm (outer diameter) guide catheter through which a 1.1 
mm (outer diameter) catheter was advanced into the left 
anterior descending artery after the guide catheter was 
positioned in the left main coronary ostium. The coronary 
artery catheter was advanced approximately 1 cm beyond 
the bifurcation of the left main coronary artery and was used 
to infuse acetylcholine and prostaglandin F,,. Prostaglandin 
F,, infusion was used to constrict the anterior descending 
artery before exposure to acetylcholine in five dogs to 
evaluate the effect of increased tone on arterial responsive- 
ness to acetylcholine. Infusion of prostaglandin FZa was also 
performed after endothelium removal. 
Coronary blood flow measurements. Blood flow was mea- 
sured in the left anterior descending artery by injecting 
xenon-133 through the coronary artery catheter positioned in 
the proximal anterior descending artery. Isotope washout 
was monitored by a single crystal detector positioned at the 
left chest mid-ventricular level under fluoroscopic guidance. 
Xenon flow data were transferred directly to a PDP 11/34 
computer (Digital Equipment Corporation) for a period of 2 
min after isotope injection. Flow was then calculated in 
mllmin per 100 g left ventricle from the monoexponential 
log-linear least squares calculation for the slope (k) of the 
washout curve using -0.72 k/1.05, where 0.72 is the xenon 
blood-myocardium partition coefficient and 1 .OS is myocar- 
dial density (23). Flow was also calculated using the height/ 
area method of washout curve analysis (24); results are 
comparable by the two methods. Arteriovenous oxygen 
differences were calculated from the difference between 
arterial and coronary sinus blood oxygen content (ml O,/dl) 
with oxygen content calculated from the product of hemo- 
globin (g/100 ml) x 1.34 ml 0,/g x fraction oxygen satura- 
tion. 
Angiographic analysis of left anterior descending artery 
dimension. Quantitative coronary angiograms were com- 
pleted with each intervention to obtain measurements of left 
anterior descending diameter and cross-sectional area by a 
computerized analysis system (25). Nonionic contrast me- 
dium (6 ml of Omnipaque 350 [iohexol], Wintrop-Breon 
Laboratories) was injected through the guide catheter into 
the left main coronary artery, and single right anterior 
oblique projection roentgenographic films (17.8 x 25.4 cm) 
were obtained. Exposure was made at 85 kV for 25 ms in 
mid-diastole and end-expiration using an electrocardiogram 
(ECGI-triggered X-ray switch. The luminal edges of the left 
anterior descending and circumflex arteries were manually 
traced and digitized with the computerized angiographic 
program (25). The program calculates luminal diameter and 
cross-sectional area at 1 mm intervals along the length of the 
artery scanned. On the basis of each individual angiogram, a 
2 to 3 cm long segment of the left anterior descending artery 
that extended from a common reference point 1 cm beyond 
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the bifurcation of the left main coronary artery was ana- 
lyzed. This segment incorporated the area of the vessel 
denuded of endothelium. Testing and assessment of the 
effects of respective injections of contrast medium on coro- 
nary responsiveness and of the angiographic method of 
analysis have been previously reported (26,27). 
Experimental protocols. The first protocol involved two 
groups of five dogs each. One group of dogs received 
intracoronary acetylcholine infusion without prostaglandin 
F,,. In the second group, the left anterior descending artery 
was constricted with prostaglandin F,, (40 pg/min); this 
intracoronary infusion was then continued during subse- 
quent acetylcholine infusions. Prostaglandin F,, has been 
demonstrated (17) to be an endothelium-independent vaso- 
constrictor capable of sustaining uniform vascular smooth 
muscle constriction in vitro and, therefore, should be capa- 
ble of constricting coronary arteries in vivo independently of 
endothelial interactions. This protocol is thus comparable 
with in vitro experiments that are designed to optimize 
endothelium-dependent vasorelaxant effects of acetylcho- 
line. Maximal stable constriction of the anterior descending 
artery was achieved by 4 min of prostaglandin F,, infusion. 
Control measurements of left anterior descending flow (Xe- 
non-133 washout, in duplicate), arterial and coronary sinus 
oxygen saturation and arterial partial pressure of oxygen 
(PoJ and partial pressure of carbon dioxide (Pco,). Proximal 
left coronary artery blood pressure, pH, heart rate and a left 
coronary angiogram were obtained before any drug infusion 
was begun. Respiratory rate and tidal volume were adjusted 
as necessary to maintain pH and blood gases within accept- 
able ranges (pH 7.34 to 7.44; Pco? 35 to 45 mm Hg; PO, 140 
to 200 mm Hg). 
Acetylcholine was infused into the left anterior descend- 
ing artery at four rates (2.5, 12.5, 25 and 125 hg/min) with 
use of a constant flow syringe pump. Acetylcholine doses 
were calculated to expose the intravascular surface to a 
concentration range corresponding to lo@ to 5 x lop6 M 
acetylcholine. Blood flow, pressure and a coronary angio- 
gram were recorded after 4 to 6 min of acetylcholine infusion 
when vessel and hemodynamic responses had stabilized. 
Maximal infusion volume was 0.4 mllmin; drugs were dis- 
solved in normal saline solution. After completion of the 
initial acetylcholine dose-response curve, all infusions were 
discontinued for 90 min to permit the effects of acetylcholine 
and prostaglandin F,,-induced constriction to dissipate and 
to reestablish control baseline values. After this recovery 
period, control measurements were again obtained. 
The endothelium of the left anterior descending artery 
was then removed by using a balloon-tipped angioplasty 
catheter (2.0 mm outer diameter, inflated) that was advanced 
through the guide catheter 3 cm beyond the tip of the 
infusion catheter, inflated and then withdrawn. This proce- 
dure was repeated five times over a 40 s period. The 
procedure removes the endothelium without injury to deeper 
layers of the arterial wall (28). An angiogram was then 
obtained 20 min after completion of the endothelium removal 
procedure, a time period that has been shown (27,29) to be 
sufficient to allow the resumption of stable vessel responses 
after removal of the endothelium. Prostaglandin F,, infusion 
was then restarted in the one group, and the dose-response 
curve for acetylcholine repeated. Similarly, the acetylcho- 
line dose-response curve was repeated in the other group 
without prostaglandin F,, vessel constriction. A bolus of 
nitroglycerin (200 pg) was given at the conclusion of each 
dose-response curve in the presence of the maximal acetyl- 
choline dose to assess reserve vasodilative potential in the 
endothelium-removed vessels. 
In the second protocol, an identical format to that of the 
first was followed except that the experiments (n = 5) were 
conducted in the presence of indomethacin (3 mg/kg body 
weight) given as an intravenous bolus after initial control 
measurements and angiogram were completed. Only two 
doses of acetylcholine were infused (25 and 125 pg/min), and 
no constriction with prostaglandin F,, was employed. 
Histologic evaluation of endothelial removal. After com- 
pletion of the study and sacrifice of the dog under anesthesia, 
segments of the left anterior descending (endothelium re- 
moved) and circumflex (endothelium intact) arteries were 
dissected free of the myocardium and stained to evaluate the 
extent of de-endothelialization. The vessels were opened 
longitudinally and stained in vitro with silver nitrate (30) for 
visualization of the endothelium under light microscopy. 
This technique verified intact endothelium in the circumflex 
artery and loss of endothelium in the anterior descending 
artery. Prior published studies from our laboratory (28) have 
established by electron microscopy the effectiveness and 
reproducibility of this technique for endothelial disruption. 
Statistical analysis. Left anterior descending artery cross- 
sectional area, coronary blood flow, mean arterial pressure, 
heart rate and arteriovenous oxygen difference were ana- 
lyzed for changes in absolute values or as percent change 
from control measurements for each dose of acetylcholine in 
vessels with and without endothelium. Data were analyzed 
with two-way analysis of variance and Student’s t test for 
unpaired observations. Statistical significance level was es- 
tablished at p < 0.05. Data are expressed as mean values -t 
standard error of the mean. 
Results 
Response of the nonconstricted left anterior descending 
artery to acetylcholme. Acetylcholine initiated dose-depen- 
dent dilation in vessels with intact endothelium; the maximal 
dose of acetylcholine produced a 35 + 6% increase in left 
anterior descending artery cross-sectional area (Fig. 1). Sub- 
sequent removal of the endothelium did not significantly 
change basal cross-sectional area (Fig. 1) nor did removal of 
the endothelium alter vessel cross-sectional area over a 2 h 
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Figure 1. Changes in left anterior de- 8 10 
scending artery cross-sectional area 
E o 
with intracoronary acetylcholine (Ach) .!z -10 
infusion before and after (DE) removal $ -20 
of the endothelium. Data are expressed 5 -30 
as percent change from control cross- 5 -40 
sectional area. 
observation period in a separate group of five dogs that 
CDE -. 1 
received no drug infusions (Fig. 2). However, in vessels 
without endothelium, acetylcholine no longer increased 
cross-sectional area but produced vasoconstriction, with the 
maximal dose (125 pg/min) causing a 3 1 k 7% decrease from 
control area measurements (Fig. 1). The response to acetyl- 
choline infusion in some animals resulted in complete occlu- 
sion of the left anterior descending artery. Figure 3A shows a 
vasospastic response to acetylcholine (125 &min) in an 
endothelium-removed anterior descending artery; Figure 3B 
shows the restoration of cross-sectional area when the ace- 
tylcholine infusion was discontinued (approximately 2 min). 
Vasospasm with complete occlusion of the anterior descend- 
ing artery was elicited by the maximal dose of acetylcholine in 
3 of 10 dogs with the endothelium removed. 
Intracoronary nitroglycerin (2OOpg bolus) in the presence 
of acetylcholine infusion (125 pglmin) reversed the acetyl- 
choline-induced constriction of the anterior descending ar- 
tery to control levels (Fig. 1). Left circumflex coronary 
artery dimensions were not changed in the presence of 
subselective left anterior descending artery infusion of ace- 
tylcholine or removal of the endothelium from the anterior 
descending artery (data not shown). 
Figure 2. Cross-sectional area of left 
anterior descending artery measured 
by quantitative angiography before and 
after (DE) endothelium removal. 
Cross-sectional area determined at I5 
min intervals over a 2 h period after the 
endothelium was removed by balloon- 
tipped catheter. Data are expressed as 
percent change from control cross- 
sectional area. 
lo Acetylcholine, pglmln 1” /, 
Response of prostaglandin FzBconstricted left anterior 
descending artery to acetylcholine. Infusion of prostaglandin 
F,, produced the same degree of constriction with or with- 
out an intact endothelium (-30 rf- 3% and -28 2 7%, 
respectively) (Fig. 4). Removal of the endothelium did not 
significantly affect basal cross-sectional area. Dose- 
dependent dilation to acetylcholine was observed in the 
presence of endothelium. The maximal dilation was 23 + 5% 
above control area measurements; this increase was compa- 
rable with the increase in cross-sectional area that developed 
in the absence of prostaglandin F,, (Fig. 1). Removal of the 
endothelium resulted in acetylcholine-induced constriction 
of the anterior descending artery in a dose-dependent man- 
ner beyond that produced by prostaglandin F,, alone. In the 
presence of increased vessel tone, the maximal acetylcholine 
dose reduced anterior descending artery cross-sectional area 
66 k 6% below control area measurement; this was a further 
38% reduction below the prostaglandin F,,-constricted 
cross-sectional area. Intracoronary nitroglycerin reversed 
the constrictor effect of acetylcholine. but not that of pros- 
taglandin Fzcr (Fig. 4). 
Hemodynamic responses to acetylcholine. lntracoronary 
infusion of acetylcholine resulted in an increase of the heart 
c t 15 30 45 60 75 90 105 120 
DE 
Time after endothelium removed, min 
1798 MILLER ET AL. 
INDOMETHACIN-ATTENUATED CONSTRICTION TO ACETYLCHOLINE 
rate above control levels only with the two highest doses in 
the endothelium-intact, group with the maximal change 
being from 90 to 107 beatslmin. Mean pressure, however, in 
the proximal left coronary artery was decreased significantly 
only at one point, and that was at the highest dose of 
acetylcholine in the endothelium-removed group (Table 1). 
Prostaglandin F,, did not affect heart rate or mean arterial 
pressure either alone or with acetylcholine infusion. 
Coronary flow response to acetylcholine. Left anterior 
descending artery blood flow was increased by acetylcholine 
infusion when the endothelium was present; however, a 
consistent dose-response increase was not observed. In 
contrast, left anterior descending artery blood flow remained 
at or below control levels in response to acetylcholine when 
the endothelium was removed by the balloon catheter. The 
reduction in blood flow at the highest dose may reflect the 
effect of the decrease in perfusion pressure observed with 
this dose of acetylcholine. Prostaglandin F,, alone increased 
anterior descending artery blood flow in both the presence 
and the absence of endothelium. Acetylcholine, however, in 
the presence of prostaglandin F,, further increased left 
anterior descending artery blood flow only when the endo- 
thelium was intact. Decreased flow was observed when the 
endothelium was removed, although the reduction in flow 
was not statistically significant. Coronary blood flow by the 
xenon-133 clearance technique is calculated using the parti- 
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Figure 3. A, Right anterior oblique left 
coronary angiogram showing complete 
occlusion of the mid left anterior de- 
scending artery (arrow) in response to 
acetylcholine infusion (125 CLglmin in- 
tracoronary). B, Restoration of coro- 
nary perfusion 2 min after discontinu- 
ation of acetylcholine infusion. The 
intracoronary catheter tip is indicated 
by the radiopaque marker shown in the 
proximal left anterior descending ar- 
tery. 
tion coefficient for xenon established previously (23). Abso- 
lute measurements higher than those reported for other 
techniques suggest that this coefficient may be different in 
this model. Relative changes in blood flow with experimental 
manipulation, however, remain valid and provide the basis 
for analysis of drug effects on coronary flow. 
Arteriovenous oxygen differences in response to acetyl- 
choline infusion were unchanged or reduced when the endo- 
thelium was intact. The decreases in arteriovenous oxygen 
difference reflect the increased left anterior descending ar- 
tery blood flow in these groups; no increases in arteriove- 
nous oxygen differences were observed. Coronary artery 
PO, was 173 2 9 mm Hg (control), with an oxygen saturation 
of 87 k 0.6% in the coronary artery and 48 ? 2.5% in the 
coronary sinus. 
Effect of indomethacin on acetylcholine-induced left ante- 
rior descending artery constriction. Indomethacin did not 
alter basal left anterior descending artery cross-sectional 
area (3.97 +- 0.38 to 4.41 ? 0.21 mm’) and did not change the 
vasorelaxant response to acetylcholine in the endothelium- 
intact vessels (Fig. 5). In the vessels with the endothelium 
removed, indomethacin did not alter baseline cross-sectional 
area from control levels. The response to acetylcholine (25 
pg/min), however, was significantly altered, in that in the 
presence of indomethacin, a vasorelaxant response was 
observed that was comparable with that observed in endo- 
Figure 4. Change in left anterior de- 
scending artery cross-sectional area 
with intracoronary acetylcholine (Ach) 
infusion in the presence of prostaglan- 
din F,, (PGF,,)-induced constriction 
before and after removal (DE) of the 
endothelium. Data are expressed as 
percent change from control cross- 
sectional area. 
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Table 1. Changes in Hemodynamic and Metabolic Variables With Intracoronary Acetylcholine Infusion in the Presence and 
Absence of Endothelium 
Control 
(n = 10) Endothelium 
PGFzu 
(n = 5) 2.5 
Acetylcholine (Fg/min) (n = 5) 
12.5 25 125 
MAP (mm Hg) 
proximal left 
coronary 
artery 
Heart rate tmiK’) 
Blood flow in LAD 
(mUmin per I00 g) 
A av O2 
(ml 0, per dl) 
88 2 4 
89 i- 5 
90 + 3 
92 + 2 
202 + 18 
175 t I? 
5.33 + 0.40 
5.58 + 0.35 
Intact 
DE 
Intact 
DE 
Intact 
DE 
Intact 
DE 
Intact 
DE 
Intact 
DE 
Intact 
DE 
Intact 
DE 
- 
- 
92 t 6 
99 ? 9 
- 
- 
92 ? 1 
85 _t 3 
- 
- 
220 t 16* 
217 2 17* 
- 
5.57 is 0.36 
5.59 + 0.62 
9028 
89 ? 4 
95 i 8 
100 + 8 
95 ? 6 
9026 
92 2 3 
9023 
258 + 19* 
206 k 20 
244 z 9 
197 2 16 
5.17 2 0.28 
5.65 f 0.57 
4.03* i- 0.20 
6.10 f 0.63 
89 -+ 8 88 + 5 85 + 7 
81 2 5 82 + 8 69 + 8* 
98 2 7 89 2 8 92 + 7 
97 2 7 97 2 8 91 t6 
104 k 8 106 i 8* 107 * 8* 
100 2 7 96 t 8 99 c 7 
97 ? 7 88 +- 4 87 + 6 
84 k 6 90 % 5 88 t 4 
245 i 31* 268 k 35* 232 ? 49 
195 k 27 202 k 27 125 t 16 
224 ? 16* 230 + 24 192 2 19 
156 2 21 I58 2 16 155 2 15 
5.12 ? 0.37 4.43* t 0.29 5.37 ? 0.82 
5.78 2 0.51 5.99 + 0.60 5.99 + 0.63 
4.10* + 0.17 3.93* i- 0.26 4.38 t 0.77 
5.84 c 0.59 5.82 ? 0.43 5.68 2 0.32 
*p < 0.05. Values are mean values C SEM. A av O? = arteriovenous oxygen difference: LAD = left anterior descending coronary artery blood Row; DE = 
denuded endothelium; MAP = mean arterial pressure; PGFz, = prostaglandin FzO. 
thelium-intact vessels (Fig. 5). The previously observed 
(Fig. 1) acetylcholine-induced decrease in cross-sectional 
area was abolished. At the higher acetylcholine dose (125 
pg/min), left anterior descending artery area was decreased 
compared with the response in the endothelium-intact vessel 
at this dose. The area was not different from control area 
measurements in contrast to the response to acetylcholine 
(125 pg/min) in the absence of indomethacin. Left anterior 
descending artery cross-sectional area was measured at the 
completion of the acetylcholine infusions and was not dif- 
ferent from the initial cross-sectional area. Also. the re- 
Figure 5. Change in left anterior descending artery cross-sectional 
area with intracoronary acetylcholine infusion in the presence of 
indomethacin (Indo) (3 mg/kg intravenously) before and after re- 
moval (DE) of the endothelium. Data are expressed as percent 
change from indomethacin cross-sectional area. 
- Endothalium mnwed 
* 
??
I 
- 4.41 mm2 
L 0.24 
I 
lndo DE 1 
Acetylcholine, wglmin 
sponse to nitroglycerin remained intact. Left anterior de- 
scending artery pressure and heart rate were not changed 
from control values with indomethacin or acetylcholine 
infusion in either the endothelium-intact or endothelium- 
removed vessels (Table 2). 
Discussion 
Acetylcholine-induced coronary artery constriction. This 
study demonstrates that acetylcholine-induced coronary ar- 
tery constriction that occurs after endothelial injury can be 
reversed by an inhibitor of platelet function and suggests that 
platelets participate in acetylcholine-induced vasoconstric- 
tion in vivo. 
Table 2. Changes in Hemodynamic Variables With 
Acetylcholine Infusion in the Presence of Indomethacin 
With and Without Endothelium 
Control 
(n = 5) Endothelium 
MAP (mm Hg) 
proximal left 
coronary 
artery 
Heart rate (min-‘) 
101 + 8 
91 f 2 
Intact 
DE 
Intact 
DE 
Acetylcholine 
@timin) 
25 125 
96 t 6 882 10 
96 2 8 902 11 
94 + 2 91 +2 
91 ” 2 98 + 6 
Values are mean values ? SEM. Abbreviations as in Table 1 
1800 MILLER ET AL. 
INDOMETHACIN-ATTENUATED CONSTRICTION TO ACETYLCHOLINE 
JACC Vol. 14, No. 7 
December 1989: 1794-802 
Atherosclerotic coronary arteries in humans have been 
shown to respond to acetylcholine infusion with vasocon- 
striction (13,16,20,21), and methacholine-induced Prinzmet- 
al’s angina has been reported (14,31). However, the status of 
the endothelium in these studies was not established. Direct 
constrictor action by acetylcholine on coronary vascular 
smooth muscle has been suggested by studies on isolated 
bovine coronary artery strips (32) and helical strips of rabbit 
aorta (33). Most reports (6,9,34) of isolated canine coronary 
vessels, however, indicate the loss of vasodilator response 
with removal of the endothelium, but not the development of 
constrictor responses. Our study demonstrates that acetyl- 
choline infusion can produce significant decreases in coro- 
nary artery cross-sectional area after the endothelium is 
removed-even to the point of total occlusion. In addition, 
increased basal tone induced by prostaglandin F,, does not 
mitigate the constrictor response to acetylcholine, but re- 
sults in an augmented constrictor response to acetylcholine. 
Role of endothelial damage and platelet aggregation. The 
findings of this study indicate that endothelial damage im- 
pairs the release of endothelium-derived relaxing factor (or 
factors), which modulates vascular smooth muscle re- 
sponses to acetylcholine and permits a direct vasoconstric- 
tor effect of acetylcholine to overwhelm any effect of the 
endothelium-derived relaxing factor (or factors). Another 
possible contributing mechanism involves the interaction of 
endothelial damage, loss of endothelial-derived factors (in- 
cluding prostacyclin) and aggregating platelets stimulated by 
the infused acetylcholine to release vasoconstrictor sub- 
stances (19). This hypothesis raises the question of the 
relative role of endothelial dysfunction in the vasoconstric- 
tor response in vivo to acetylcholine (Fig. 6). That aggregat- 
ing platelets have been shown to cause contractions in 
isolated canine coronary arteries without endothelium 
through S-hydroxytryptamine (serotonin) and thromboxane 
A2 release (17,35) supports such a hypothesis; additional 
evidence (36) suggests that acetylcholine-induced contrac- 
tion of intrapulmonary rabbit arteries is mediated by throm- 
boxane A,. 
Acetylcholine has been shown (19) to induce aggregation 
of canine platelets and the release of Shydroxytryptamine 
from platelets. Therefore, acetylcholine may also produce 
vasoconstriction in vivo by promoting the release of vaso- 
constrictor substances from platelets aggregated at the sites 
of endothelial disruption. Our data showing that indometh- 
acin, which inhibits cyclooxygenase and thereby the synthe- 
sis of thromboxane A, by platelets, prevents the acetylcho- 
line-induced vasoconstriction and restores the vasorelaxant 
response in the endothelium-removed vessel support such a 
proposed mechanism. Further supporting a role for platelet 
deposition at the site of endothelial injury and consequent 
vasoconstriction is the demonstration in vivo of the correla- 
tion between platelet deposition and the degree of localized 
vasoconstriction at the site of balloon angioplasty injury of 
A ACH . 
PGI, j I- - :- 
Figure 6. Postulated mechanisms of acetylcholine-mediated contrac- 
tion of coronary vascular smooth muscle. A, Intact endothelium. 
Endothelium-dependent relaxation of vascular smooth muscle to 
acetylcholine (ACH) through release of endothelium-derived relax- 
ing factor (EDRF) and prostacyclin (PC&). - = vasorelaxation. B, 
Damaged endothelium with platelet aggregation. Acetylcholine- 
mediated platelet release of vasoconstrictors thromboxane A, 
(TXA,) and serotonin (5HT) and direct vasoconstrictor effect of 
acetylcholine on vascular smooth muscle. - = vasorelaxation; t = 
vasoconstriction. 
the porcine carotid artery (18). Platelet inhibition therapy 
was also shown (37) to reduce the vasoconstrictor response 
to injury of the carotid artery, suggesting that a secondary 
mechanism such as platelet activation is necessary for the 
development of a vasoconstrictor response. 
The mechanism of the vasorelaxant response to acetyl- 
choline in endothelium-removed vessels in the presence of 
indomethacin is not clear, but may reflect the effects of 
adequate endothelium-derived relaxing factor (or factors) 
released from adjacent intact endothelium in the setting of 
indomethacin-induced platelet inhibition. A direct vascular 
smooth muscle effect by indomethacin, either vasodilator or 
vasoconstrictor, has not been demonstrated except at anti- 
inflammatory doses (27) greater than those used in the 
current study to produce platelet inhibition. Further, if 
endothelial function was primarily affected by indomethacin, 
then additional vasoconstriction and not vasodilation would 
be expected to occur because the endothelium releases 
vasodilator substances, and indomethacin has been shown to 
block the synthesis of endothelium-derived vasodilators (for 
example, prostacyclin). At the high acetylcholine dose (125 
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pg/min), the antiplatelet effects of indomethacin were over- 
whelmed or the direct constrictor effect of acetylcholine on 
the vascular smooth muscle predominated, or both. 
Role of prostaglandin F,,-reduced vasoconstriction. The 
maximal dilator responses to acetylcholine infusion were 
comparable in the presence and absence of increased vessel 
tone produced by prostaglandin F,,. This suggests that the 
tone at rest of the left anterior descending artery in vivo is 
low. Also, the presence of endothelium does not appear to 
be necessary to sustain tone at rest in vivo under these 
experimental conditions in that vessel dimensions were not 
observed to change over 120 min after removal of the 
endothelium. Nitroglycerin, an endothelium-independent 
vasodilator, reversed the acetylcholine-induced contraction 
to baseline dimensions, but did not antagonize the contrac- 
tion induced by prostaglandin FZa. This may, however, have 
been a dose-limited vasodilator response to the prostaglan- 
din F,, constriction. The vasoconstriction effect of prosta- 
glandin F,, was demonstrated in vivo by our study and in 
vitro by others (17) to be an endothelium-independent mech- 
anism in that removal of the endothelium did not change the 
magnitude of the constrictions observed (approximately a 
30% decrease in cross-sectional area). Baseline cross- 
sectional area was restored in approximately 90 min after 
discontinuation of prostaglandin F,, infusion. 
Conclusions. This study supports in vitro findings of 
endothelium-dependent vasorelaxation in response to ace- 
tylcholine and endothelium-independent vasoconstriction in 
response to prostaglandin F,, and further demonstrates in 
vivo that significant constriction and spasm of the left 
anterior descending coronary artery are produced by acetyl- 
choline in the endothelium-damaged vessel. The mechanism 
of constriction is not certain, but is likely to involve several 
mechanisms including a direct action of acetylcholine on 
vascular smooth muscle, the loss of endothelium-derived 
relaxing factor (or factors) secondary to endothelial removal 
or damage and an indirect action of acetylcholine by 
means of bloodborne products such as aggregating plate- 
lets to stimulate the release of vasoconstrictor substances 
at the site of endothelial injury. The effect of indomethacin 
in preventing the constrictor response to acetylcholine 
suggests that platelet aggregation and release of vasocon- 
strictor substances at the site of endothelial damage may 
be contributing to the vasoconstrictor response to acetylcho- 
line observed in vivo. This would suggest that the absence of 
an intact endothelium may not be the sole mechanism 
contributing to the vasoconstriction by acetylcholine in 
vivo. 
We thank Jerry Dewey and Curtis Grabau for excellent technical assistance in 
the laboratory, and Carol Davidson for patience and skill in preparing the 
manuscript. 
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